Profile of breast cancer patients receiving government sponsored free treatment and the associated economic costs
Abstract
Background Incidence of breast cancer in India is on raise and shows a 3–4 fold variation across the country. Materials and methods In this retrospective study, a total of n=181 histopathologically confirmed breast cancer cases who visited the tertiary Government hospitals during the period March 2016 to March 2017 were studied. Results Majority of the patients (n=108) are of the age group 40 to 59 years. Most of the women (n=112, 61.9%) belong to the Socio-economic class of Backward caste. Right breast is the common site of occurrence of breast cancer. Histological Grade II (n=95, 59.0%) is highly predominant. Invasive carcinoma of no special type (NST), is the most common histological type of breast tumor in 173 (95.6%) patients. Clinical stages of T2 (n=76, 42%), N1 (n=68, 37.6%) and M0 (n=163, 90.1%) were the most common stages. Triple negative breast cancer was noticed in (n=24, 28.9%) out of 83 patients analysed. Modified radical mastectomy (n=134, 74.0%) is the common surgical procedure followed in treating breast cancer. The total claim amount paid ranged from Rs. 10000 to 49999/- (US$ 154.98 -US $ 774.88) with the Mean cost incurred being Rs. 48,477/- (± Rs. 29,082 SD) which equals to US$ 748.97. Conclusion Majority of the patients are diagnosed at a later stage due to lack of awareness and access to preventive diagnostic services. Region specific research and planning evidence based preventive programs is the need of the hour.
Read the paper
Related studies
- Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale
- Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
- Exercise interventions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials
- Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
- Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.